T4	Treatment 109 133	cyclophosphamide therapy
T5	Effect 4 52;79 95	development of erythroid leukemia plus carcinoma mutagenic change
T6	Subject 62 69	two men
T7	Population 62 65	two
T8	Gender 66 69	men
T10	Drug 109 125	cyclophosphamide
